期刊文献+

骨缺损修复机制探讨 被引量:12

The mechanism of the healing of long bone defect
下载PDF
导出
摘要 目的通过引导性骨再生和组织工程软骨移植研究长骨骨缺损的修复机制。方法实验组在几丁质纤维载体上增殖21d的新生兔关节-干骺端复合物的软骨细胞(含载体)被装入硅胶管内,移植到成年兔桡骨干1cm的缺损上,对照组骨缺损处仅套接空套管。结果实验组术后4周时3例移植的软骨细胞在骨缺损内均形成软骨样组织,术后16周时9例中仅2例缺损愈合。对照组术后16周时9例(空套管)均骨性愈合。新生兔四肢关节-干骺端软骨细胞移植到同种成年兔桡骨缺损区后未修复骨缺损,未再现软骨内化骨过程。同时移植物可能因为占据空间、防止骨髓的成骨成分进入等原因中断了骨缺损修复过程。结论骨缺损的修复可能是先由骨膜增生形成成骨空间,然后由骨髓成分成骨,也就是一个在骨膜保护下的骨髓作用为主的天然的引导性骨再生过程。 Objective Study the mechanism of the healing of bone defect after transplantation of the tissue-engineered cartilage into the bone defects and with guided bone regeneration tubes.Method The chondrocyte harvested from the articular-epiphysis complex of a newborn rabbit was cultured in vitro with fibrous chitin mash for 21days. Then the mash with chongrocyte were transplanted into the defects of the radius of 12 adult rabbits in silicon tubes (study group), while the defects in control group were bridged with empty silicon tubes. Result 4 weeks late, 3 of the defects in the study group were filled with cartilage-like tissue that was disappeared in 16 weeks. 2 of the other defects healed with bone in 16 weeks. Control group: all of the 9 defects healed 16 weeks.The osteogenic process did not happen in the tissue-engineered cartilage in the bone defects. The transplanted cartilage did not change into bone itself, and it may block the ostrogenic factors of bone marrow from entering the defects. Conclusion The healing of bone defect might be an osteogenic process of bone marrow under the protection of proliferated periosteoum. The mechanism of guided bone regeneration might be the strengthening of the nature “guiding tube”-the generation of the periostium.
机构地区 解放军总医院
出处 《中国临床康复》 CSCD 2002年第2期186-187,共2页 Chinese Journal of Clinical Rehabilitation
关键词 软骨细胞移植 骨缺损 引导性骨再生 长骨缺损 软骨化骨 骨缺损修复机制 epiphysis cartilage transplantation bone defect guided bone regeneration
  • 相关文献

参考文献4

二级参考文献14

  • 1[1]Lanza RP,Langer R,Chixk W. Principle of tissre engineering:Bone and cartikage reconstruilage reconstuction [J]. A Card Press,1996, 619- 652
  • 2[2]Sims CD,Butler PE,Cao YL ,et al. Tissue engineered neocartilage us-ing plasma derived polyme substrates and chondrocytes[J]. Plast Re-constr Surg,1998,101(6):1 580- 1 585
  • 3[3]Sittinger M. Artificial tissues in perfusio culture[J]. Int J Artificial org- ans,1997,20(1) :57- 62
  • 4[4]Pue lacher WC, Monly D, langer R,et al.Desgn of nasoseptal latilarge relacemente sunthessged from bodegradable polymers and chondrocytes[J]. Biomaterials, 1994,15(10):774- 778
  • 5[5]Davis MW, Vacanti JP. Toward and development of an implant- able tissue engineered liver[J]. Biomaterials, 1996,17(3):365- 372
  • 6[6]Freed CE, Vun jak- novakovic G, Iron KJ. Biodegradable polymer scaf folds for tissue engineering[J]. Biotechnology NY,1994,12(7) :689
  • 7[7]Kim BS, Mooney DJ. Development of biocompatible synthetic extracel lular matrices for tissue engineering[J]. Trends Biotechnol, 1998,16(5) :224
  • 8[9]Agrawa JCW, Athanasion KA. Technigue to control PH in vicinity of biodeg rading PLA- PGA implants[J]. J Biomed Mater Res ,1997,38 (2):105- 114
  • 9曾名勇,中国海洋药物杂志,1995年,14卷,49页
  • 10伍茂福,中国生化药物杂志,1995年,10期,104页

共引文献83

同被引文献59

引证文献12

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部